Connect with us


Alcoholism and CBD Applications



In this article, we’re going to explore the potential that CBD holds for those suffering from alcoholism. Alcoholism occurs when an individual becomes predisposed toward abusing alcohol in their consumption. In such a case, an individual can become dependent upon this substance at a deep neurochemical level.

In short, an alcoholic is someone who has evolved a relationship with alcohol of true dependency or addiction such that the individual has difficulty feeling normal in their everyday life without alcohol. Recent research suggests that CBD can potentially be an important treatment for such individuals especially when they truly want to quit.

However, without CBD, it may be the case that individuals reach a point where they find it all too difficult to quit drinking alcohol even when they want to once this affliction has taken root.

Alcoholism, Addiction, and Withdrawal

One of the most important things to consider with alcoholism is that of resistance or tolerance that can build toward this drug. In such cases, individuals will need to consume additional amounts of alcohol to reach the same level of intoxication as they may have with just a small amount in the past.

Furthermore, when an individual becomes dependent upon alcohol, and then they attempts to quit drinking, we see symptoms of what is known as “withdrawal”.

Withdrawal symptoms can be terrible and violent and very disruptive in life. Such a condition can be marked by factors such as fatigue heart palpitations, anxiety, depression, irritability, and even the development of tremors.

Alcoholism is actually quite common. In fact it ranks third from the top of the list on a list of all types of deaths that are seen as preventable. And this is very costly to society.

According to some estimates the cost of alcoholism to society can even exceed $200 billion because this includes injuries, deaths, and hospitalizations that extend from alcohol abuse.

Given these statistics, it’s imperative that we as a society find new solutions to combat this terrible affliction.

CBD: A New Path in the Fight Against Alcoholism

In February of the year 2014, research was undertaken to measure alcoholism as it relates to the CB1 receptors.

These receptors are part of the Endocannabinoid system and are mainly found as part of the nervous system. In this study, it was found that signals from Endocannabinoid receptors in the brains of alcoholics respond differently than those for non-alcoholics.

In fact, those that drink socially but are not dependent upon alcohol were found to have more active CB1 receptors. This was seen to be the case even after ethanol was injected into the circulatory system. And this effect remained in place for as much as four weeks after the study even with no new alcohol.

To treat alcoholism with CBD, it is important that an individual gets to the point where they almost desperately wish to quit drinking. Once an individual is at that stage, they should be introduced to CBD.

CBD has the effect of engendering the feeling of satisfaction or contentment which replaces the cravings associated with an alcoholic who has no access to alcohol. This replacement of the subjective sensation of reward, or satisfaction or contentment, can do much to alleviate symptoms associated with alcoholism that perpetuate the disease.

New Hope Emerges

As new research begins to come into place, CBD is being seen as a potential treatment or therapy for a wide range of different conditions. Alcoholism is one of the most recent to be understood as amenable to this type of treatment.

In this case, alcoholics may benefit from CBD to the extent that it can reduce their cravings for alcohol as they are attempting to quit. This can be especially useful once an alcoholic has come to terms with the true need to quit drinking.

In such cases, data is beginning to suggest that CBD can provide much needed satisfaction as a substitute for the damaging habit of alcohol abuse.


WeedMD Inc (OTCMKTS:WDDMF) Rolls Out Its Color Cannabis Brand For Adults



WeedMD Inc (OTCMKTS:WDDMF) has announced the launch of its latest brand called Color Cannabis as a premium brand that targets adult users that want high-grade cannabis products.

The new Color Cannabis premium brand features numerous strains of cannabis that are presented in multiple formats. However, they are also developed such that they have a high level of quality as per the expectations of the target consumers. WeedMD’s new brand will only be available to a few distributors and retailers in Canada.

WeedMD plans to have the Color Cannabis-branded products in select stores as well as online availability by Mid-June. The company created the brand with a strategic aim at the diverse preference and tastes of the modern-day cannabis consumer.

“We worked with globally-renowned agency Sid Lee to launch Color – our first adult-use brand,” stated Brett Moon, the Senior Vice President of sales and marketing at WeedMD.

The Color Cannabis brand to mainly focus on a premium user experience

Mr. Moon also noted that Color Cannabis is designed to inspire customers to embrace life and their cannabis experience in personal and unique ways. Aside from being available in the form of dried premium flower, the new WeedMD brand also hosts new product formats over the next few months. Some of those products include gel capsules, oils and pre-rolls and they will be made available with the creation of more consumption formats.

WeedMD CEO Keith Merker stated that Color Cannabis’ goal is to grasp the progressive character, individuality, and imagination of cannabis users. The CEO noted that the goal of the brand is not to tell clients what they will feel but rather to experience the products for themselves. Merker also noted that the Color Cannabis launch represents a key milestone for the company.

WeedMD expects to juggle between the new adult cannabis brand and its medical cannabis pursuits. The company expects to produce about 150,000 kilograms through its 5.2 million square feet production capacity by 2020. The firm also expects to have enough room to handle production for medical cannabis, as well as recreational adult use. It plans to achieve this through its indoor and outdoor growth facilities.

Continue Reading


HempAmericana Inc. (OTCMKTS:HMPQ) CEO Issues Explains The Company’s Expansion



HempAmericana Inc. (OTCMKTS:HMPQ) CEO has issued a letter to shareholders addressing the expansion of the company following string orders.

HempAmericana has begun bottling of full-spectrum CBD distillate

In the letter to shareholders, the CEO indicated that the company has begun establishing growth momentum in its CBD oil production as well as the distribution business. The CEO stated that the company has started bottling of 500 mg as well as 1000 mg full spectrum CBD distillate in its ultramodern CBD production and extraction facility in Augusta Maine.

He added that the company’s initial production is expected to be around 2,000 bottles per day which will be increased gradually to around 8,000 bottles a day to meet demand. Currently, the company has more than 50,000 full spectrum distillate bottles that are ready to be shipped with tens of thousands expected to follow.

HempAmericana is equally bottling a 250 mg potency that is suitable for the CBD-for-pets market. On the high end, the CEO indicated that the company is bottling 2500 mg and 5000 mg but he asserted that they have the potential of replicating any formula.

The CEO further went on to explain that production will be distributed under the company’s proprietary brand “Weed Got Oil.” He added that the company is also pursuing an opportunity in the white label market for the quality full-spectrum distillate CBD Oil. Currently, there are over 400 brands in the CBD market with the majority turning to high capacity producers such as HempAmericana to build product inventory.

Relationship with Eagle Hemp

The company recently announced a relationship with Florida based Eagle Hemp for an initial purchase order as well as the establishment of connections for more orders in the future. The company anticipates strong demand that includes compensation for more production of CBD oil as well as its bottling technology. The first order will bring the company significant revenue input at no associated costs to labeling, bottling, and shipping.

The company’s production facility and lab are currently operating well with two bottling machines in operation. The CEO said that once they distill the interest into purchase orders they will communicate to shareholders.

Continue Reading


Medmen Enterprises Inc. (OTCMKTS:MMNFF) Expands Its Footprint In California With Acquisition Of One Love



MedMen Enterprises Inc. (OTCMKTS:MMNFF) has announced the signing of a definitive agreement for the acquisition of 100% interest in MattnJeremy, Inc. One Love Beach Club.

Acquisition of One Love

The acquisition enhances the company’s California footprint by adding a premier location that is positioned strategically between its LAX and Santa Ana locations. The One Love Beach Club is currently on a run-rate of around $6 million in gross revenue and has an unaudited EBITDA margin of about 29%.

MedMen CEO Adam Bierman stated that they were delighted to have Long Beach on bard as part of the MedMen family as the company continues its growth in the world’s leading cannabis market.

One love was founded back in 2009 and it is located in Long Beach at 2767 E Broadway between Belmont Shore and Downtown some blocks from the beach. Long Beach is located 20 miles from Los Angeles and it is the third largest city in Southern California behind San Diego and Los Angeles with a population of almost half a million.

The city is a prime location that offers attractions, oceanfront hotels, events, recreation activities, shopping, nightly entertainment, restaurants as well as art and culture. According to the Long Beach Convention & Visitors Bureau in 2018 there were approximately 7.9 million visitors who visited the city to attend various events and attractions.

The One Love owner and operator Abrams Family indicated that it had been exciting to have served the Long Beach community for the last ten years adding that they were looking forward to MedMen to continue offering the community with premium cannabis.

Details of the transaction

According to the details of the transaction MedMen is expected to pay around $13 million of which $1 million will be in cash at closing of the deal and $2 million in deferred cash. The rest of the $10 million shall be fulfilled in Class B Subordinate Voting shares. Completion of the transactions depends on regulatory approval by state and local authorities as well as other routine closing conditions. The deal is expected to be closed within 45 days.

Continue Reading

Trending Stories